Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assam El-Osta

Showing results (21-30 of 225) with videos related to

Pageof 23
Sort By:
Antioxidants & Redox Signaling|January 7, 2018
Epigenetic Contribution to the Development and Progression of Vascular Diabetic ComplicationsHanah Rodriguez, Assam El-Osta
Atherosclerosis|September 27, 2017
Epigenetic programming, early life nutrition and the risk of metabolic diseaseTomasz Block, Assam El-Osta
Medcomm|June 22, 2026
Rezatapopt and the Return of Targetable p53Yuanze Luo, Assam El-Osta
Circulation Research|December 15, 2010
Epigenetics: mechanisms and implications for diabetic complicationsMark E Cooper, Assam El-Osta
Medcomm|January 7, 2025
Targeting EZH1/2: tackling epigenetic resistance advances cancer therapyRam Abou Zaki, Assam El-Osta
Cancer Biology & Therapy|May 12, 2004
Epigenetic changes activate widespread signals in response to double-strand breaksTom C Karagiannis, Assam El-Osta
Cancer Biology & Therapy|November 13, 2004
siRNAs: mechanism of RNA interference, in vivo and potential clinical applicationsTom C Karagiannis, Assam El-Osta
Cancer Gene Therapy|May 14, 2005
RNA interference and potential therapeutic applications of short interfering RNAsTom C Karagiannis, Assam El-Osta
Experimental Cell Research|October 22, 2003
The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancerEmma K Baker, Assam El-Osta
Cancer Biology & Therapy|August 25, 2004
MDR1, chemotherapy and chromatin remodelingEmma K Baker, Assam El-Osta
Pageof 23

Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
Antioxidants & Redox Signaling|January 7, 2018
Epigenetic Contribution to the Development and Progression of Vascular Diabetic ComplicationsHanah Rodriguez, Assam El-Osta
Atherosclerosis|September 27, 2017
Epigenetic programming, early life nutrition and the risk of metabolic diseaseTomasz Block, Assam El-Osta
Medcomm|June 22, 2026
Rezatapopt and the Return of Targetable p53Yuanze Luo, Assam El-Osta
Circulation Research|December 15, 2010
Epigenetics: mechanisms and implications for diabetic complicationsMark E Cooper, Assam El-Osta
Medcomm|January 7, 2025
Targeting EZH1/2: tackling epigenetic resistance advances cancer therapyRam Abou Zaki, Assam El-Osta
Cancer Biology & Therapy|May 12, 2004
Epigenetic changes activate widespread signals in response to double-strand breaksTom C Karagiannis, Assam El-Osta
Cancer Biology & Therapy|November 13, 2004
siRNAs: mechanism of RNA interference, in vivo and potential clinical applicationsTom C Karagiannis, Assam El-Osta
Cancer Gene Therapy|May 14, 2005
RNA interference and potential therapeutic applications of short interfering RNAsTom C Karagiannis, Assam El-Osta
Experimental Cell Research|October 22, 2003
The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancerEmma K Baker, Assam El-Osta
Cancer Biology & Therapy|August 25, 2004
MDR1, chemotherapy and chromatin remodelingEmma K Baker, Assam El-Osta
Pageof 23